Publications by authors named "M Lavignon"

Previous studies indicate that mice infected with mixtures of mouse retroviruses (murine leukemia viruses [MuLVs]) exhibit dramatically altered pathology compared to mice infected with individual viruses of the mixture. Coinoculation of the ecotropic virus Friend MuLV (F-MuLV) with Fr98, a polytropic MuLV, induced a rapidly fatal neurological disease that was not observed in infections with either virus alone. The polytropic virus load in coinoculated mice was markedly enhanced, while the ecotropic F-MuLV load was unchanged.

View Article and Find Full Text PDF
Article Synopsis
  • The study compared HIV-1 residual viremia levels in patients on two different treatment regimens: nevirapine (NVP) and efavirenz (EFV), focusing on those with suppressed viral loads.
  • Among 165 patients, those on NVP showed a significantly higher percentage (81.3%) of having viral loads below 1 copy/ml compared to those on EFV (55.6%).
  • The findings suggest that NVP might provide better control of viral replication, warranting further research into its clinical implications, such as its effects on inflammation and immune activation.
View Article and Find Full Text PDF
Article Synopsis
  • Switching to a non-nucleoside reverse transcriptase inhibitor (NNRTI) regimen for HIV-infected patients with controlled viral loads was found to be safe and effective, leading to improvements in health-related quality of life (HRQL).
  • A noticeable decrease in anxiety was observed by 6 months, with significant reductions in various symptoms and improvements in the physical, independence, and spirituality aspects of HRQL also recorded.
  • The study highlighted that these positive changes in mental health and HRQL began at one month after the switch and were maintained over a year, despite no change in depression levels.
View Article and Find Full Text PDF
Article Synopsis
  • A study involving 143 patients previously treated with protease inhibitors analyzed mutations linked to the effectiveness of a tipranavir-ritonavir (TPV/r) regimen, measuring VR as a significant reduction in HIV RNA levels after 3 months.
  • Specific mutations at six locations were identified as associated with a lower virological response, while one mutation was linked to a higher response, with a genotypic score indicating strong associations with VR outcomes.
  • Non-clade B virus infections showed a significantly lower response to the TPV/r treatment compared to clade B infections, likely due to a greater prevalence of certain mutations in non-B subtype patients.
View Article and Find Full Text PDF
Article Synopsis
  • Mixed retrovirus infections are common in mice and other species, including humans, but their interactions and effects on disease are not well understood.
  • In experiments with mice infected by ecotropic Friend murine leukemia virus (F-MuLV) and polytropic viruses, it was found that mixed infections can dramatically alter disease outcomes; one combination prolonged survival while another caused severe neurological issues.
  • The study highlights how the presence of multiple retroviruses can lead to significant viral amplification and changes in disease processes, indicating that co-infections can dramatically impact viral behavior and severity of illness.
View Article and Find Full Text PDF